McKesson Corp. (MCK) News

McKesson Corp. (MCK): $446.42

7.76 (+1.77%)

POWR Rating

Component Grades








Add MCK to Watchlist
Sign Up

Industry: Medical - Services




#3 of 69

in industry

Filter MCK News Items

MCK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MCK News Highlights

  • For MCK, its 30 day story count is now at 21.
  • Over the past 21 days, the trend for MCK's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about MCK are DVA, AMZN and DHI.

Latest MCK News From Around the Web

Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.

McKesson (MCK) Announces Availability of FDA-Cleared Drug for MF

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for MF.

Yahoo | September 21, 2023

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Yahoo | September 21, 2023

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Here is how DaVita HealthCare (DVA) and McKesson (MCK) have performed compared to their sector so far this year.

Yahoo | September 21, 2023

The Zacks Analyst Blog Highlights Procter & Gamble,, Verizon Communications, McKesson Corporation and D.R. Horton

Procter & Gamble,, Verizon Communications, McKesson Corporation and D.R. Horton are part of the Zacks top Analyst Blog.

Yahoo | September 20, 2023

5 Cash Cow Stocks to Buy Now

Procter & Gamble (PG), Amazon (AMZN), Verizon (VZ), McKesson (MCK) and D.R. Horton (DHI) are some of the cash-rich companies that one can invest in.

Yahoo | September 19, 2023

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

Yahoo | September 19, 2023

Three Reasons to Add DaVita (DVA) Stock to Your Portfolio

DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.

Yahoo | September 18, 2023

McKesson (MCK)'s True Worth: A Comprehensive Analysis of Its Market Value

Is McKesson's Stock Modestly Overvalued? An In-Depth Exploration

Yahoo | September 18, 2023

Is McKesson (MCK) a Stable Stock?

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” second quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its Russell 1000 Value Index benchmark in the second quarter. The strategy benefited from nine of the 11 sectors in which it was invested for […]

Yahoo | September 14, 2023

Add These 4 Stocks With Remarkable Interest Coverage Ratio

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. STRL, SFM, MOH and MCK are sound enough to meet financial obligations.

Yahoo | September 13, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!